Literature DB >> 2190649

The role of the neutrophil in inflammatory diseases of the lung.

L A Boxer1, R Axtell, S Suchard.   

Abstract

Under certain circumstances, the neutrophil has been implicated in causing disease by damaging normal host tissue. This may occur in the adult respiratory distress syndrome (ARDS). The neutrophil has been implicated since a) substances that activate neutrophils are produced in association with the predisposing risks that lead to ARDS; b) activated neutrophils migrate into the alveolar spaces and their toxic products can be found in lung lavage fluid and in the breath of patients with ARDS; and c) the magnitude of the physiologic alterations correlate with the number of neutrophils in the alveolar space. Additionally, the neutrophils may be primed by substances which are released by activated platelets within the confines of the lung. Both platelet adenine nucleotides and the platelet-derived extracellular matrix protein (ECM), thrombospondin, can prime the neutrophil for subsequent O2- generation following activation of the cells with the chemotactic peptide, F-met-leu-phe (FMLP). Furthermore, neutrophils can be primed or O2- generation by the basement membrane ECM protein, laminin. Since neutrophils express receptors for both laminin and thrombospondin, these constituents may serve to modulate neutrophil behavior for subsequent oxidative metabolism and contribute to exacerbating pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190649

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  10 in total

Review 1.  Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor.

Authors:  Michael A Ellison; Daniel R Ambruso; Christopher C Silliman
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Quantification of pulmonary uptake of indium-111 labelled granulocytes in inflammatory bowel disease.

Authors:  W Y Ussov; A M Peters; H J Hodgson; J M Hughes
Journal:  Eur J Nucl Med       Date:  1994-01

Review 3.  Role of neutrophils in innate immunity: a systems biology-level approach.

Authors:  Scott D Kobayashi; Frank R DeLeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Nov-Dec

4.  Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation.

Authors:  G Matute-Bello; R K Winn; M Jonas; E Y Chi; T R Martin; W C Liles
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 5.  Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations.

Authors:  Kelly Swanson; Denis M Dwyre; Jessica Krochmal; Thomas J Raife
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

6.  Neutrophils in innate immunity and systems biology-level approaches.

Authors:  Viktoria Rungelrath; Scott D Kobayashi; Frank R DeLeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-06-20

7.  Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.

Authors:  C C Silliman; N F Voelkel; J D Allard; D J Elzi; R M Tuder; J L Johnson; D R Ambruso
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  Hypothesis: disseminated intravascular inflammation as the inflammatory counterpart to disseminated intravascular coagulation.

Authors:  B S Bull; M H Bull
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  Time course changes of oxidative stress and inflammation in hyperoxia-induced acute lung injury in rats.

Authors:  Shouli Yu; Min Shi; Changting Liu; Qinghui Liu; Jun Guo; Senyang Yu; Tingshu Jiang
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

10.  Microvascular reactivity is altered early in patients with acute respiratory distress syndrome.

Authors:  Diego Orbegozo Cortés; Lokmane Rahmania; Marian Irazabal; Carlos Santacruz; Vito Fontana; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent
Journal:  Respir Res       Date:  2016-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.